Sanofi/GSK restart COVID-19 vaccine trials after tweaking formulation
pharmaphorum
FEBRUARY 22, 2021
But instead rivals such as BioNTech/Pfizer, AstraZeneca and Moderna have made it to market first with their vaccines. Regulators in the US and UK are reviewing data from another vaccine from Novavax.
89 
Let's personalize your content